Literature DB >> 10675222

The London handicap scale: a re-evaluation of its validity using standard scoring and simple summation.

C Jenkinson1, J Mant, J Carter, D Wade, S Winner.   

Abstract

OBJECTIVE: To assess the validity of the London handicap scale (LHS) using a simple unweighted scoring system compared with traditional weighted scoring
METHODS: 323 patients admitted to hospital with acute stroke were followed up by interview 6 months after their stroke as part of a trial looking at the impact of a family support organiser. Outcome measures included the six item LHS, the Dartmouth COOP charts, the Frenchay activities index, the Barthel index, and the hospital anxiety and depression scale. Patients' handicap score was calculated both using the standard procedure (with weighting) for the LHS, and using a simple summation procedure without weighting (U-LHS). Construct validity of both LHS and U-LHS was assessed by testing their correlations with the other outcome measures.
RESULTS: Cronbach's alpha for the LHS was 0.83. The U-LHS was highly correlated with the LHS (r=0.98). Correlation of U-LHS with the other outcome measures gave very similar results to correlation of LHS with these measures.
CONCLUSION: Simple summation scoring of the LHS does not lead to any change in the measurement properties of the instrument compared with standard weighted scoring. Unweighted scores are easier to calculate and interpret, so it is recommended that these are used.

Entities:  

Mesh:

Year:  2000        PMID: 10675222      PMCID: PMC1736821          DOI: 10.1136/jnnp.68.3.365

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Initial validation of the Swedish version of the London Handicap Scale.

Authors:  Albert Westergren; Peter Hagell
Journal:  Qual Life Res       Date:  2006-09-13       Impact factor: 4.147

Review 2.  Quality of life of individuals born preterm: a systematic review of assessment approaches.

Authors:  Martina Estevam Brom Vieira; Maria Beatriz Martins Linhares
Journal:  Qual Life Res       Date:  2016-03-19       Impact factor: 4.147

3.  Preserved decision making ability in early multiple sclerosis.

Authors:  S Simioni; C Ruffieux; J Kleeberg; L Bruggimann; J-M Annoni; M Schluep
Journal:  J Neurol       Date:  2008-11-13       Impact factor: 4.849

4.  The significance of importance: an evaluation of Ferrans and Powers' Quality of Life Index.

Authors:  Peter Hagell; Albert Westergren
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 3.440

Review 5.  Content comparison of health-related quality of life measures used in stroke based on the international classification of functioning, disability and health (ICF): a systematic review.

Authors:  S Geyh; A Cieza; B Kollerits; G Grimby; G Stucki
Journal:  Qual Life Res       Date:  2007-02-10       Impact factor: 3.440

6.  From rehabilitation to recovery: protocol for a randomised controlled trial evaluating a goal-based intervention to reduce depression and facilitate participation post-stroke.

Authors:  Christine Graven; Kim Brock; Keith Hill; David Ames; Susan Cotton; Lynette Joubert
Journal:  BMC Neurol       Date:  2011-06-18       Impact factor: 2.474

7.  A Disease Register for ME/CFS: Report of a Pilot Study.

Authors:  Derek Pheby; Eliana Lacerda; Luis Nacul; Maria de Lourdes Drachler; Peter Campion; Amanda Howe; Fiona Poland; Monica Curran; Valerie Featherstone; Shagufta Fayyaz; Dikaios Sakellariou; José Carlos de Carvalho Leite
Journal:  BMC Res Notes       Date:  2011-05-09

8.  The Persian Version of a Participation Scale: Is It Valid and Reliable Enough for Use among Iranian Patients with Multiple Sclerosis?

Authors:  Reza Vazirinejad; Javad Joorian; Mohammad Mohsen Taghavi; Jeanette M Lilley; Ahmad Reza Sayadi Anari
Journal:  J Clin Neurol       Date:  2015-04       Impact factor: 3.077

9.  Rasch analysis of the London Handicap Scale in stroke patients: a cross-sectional study.

Authors:  Eun-Young Park; Yoo-Im Choi
Journal:  J Neuroeng Rehabil       Date:  2014-07-31       Impact factor: 4.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.